Board of Directors |
| Louis Bowen Louis Bowen is the Executive Chairman and Co-Founder of Pacific GeneTech Limited. Louis has been in the private equity and venture capital business in Asia since 1981. Prior to that, he spent nine years with Citicorp in New York including four years responsible for their Corporate Finance activities in the Asia-Pacific region from 1977 to 1981. In his 33 years of private equity and investment banking in Asia, Louis has overseen over 50 investments and acquisitions in a range of industries including pharmaceuticals, primary care services and medical diagnostics. He is the Chairman and CEO of Asia Capital Management Limited based in Hong Kong, a private investment banking company and he serves on the boards of several companies in the Asia-Pacific region. Louis received an MBA in Finance from the Wharton School and has a BA in Economics from the University of Arkansas. He was a co-founder of the Hong Kong Venture Capital Association and is a member of the World Presidents’ Organization. He currently serves on the Board of Governors of the Wharton Alumni Association of Hong Kong and is on the Board of Advisors of the Arkansas World Trade Center. He is a member of the Clinton Global Initiative. |
| Tim Collard Chief Executive Officer Tim Collard is the Chief Executive Officer of PGT and has overall technical responsibility for PGT's operations. Tim studied biology at Bristol University in the U.K. and he has worked for 35 years in the pharmaceutical and biotechnology industries. In the 1970s after leaving university he worked with Connaught Laboratories to supply human vaccines to the Hong Kong government and also established a business supplying poultry vaccines to Hong Kong farmers. He then joined Califas, a China-based consultancy, negotiating the first Sino-US joint manufacturing contract in the Chinese healthcare industry for a subsidiary of Squibb. Tim also carried out preparatory work for the Shanghai Squibb pharmaceutical joint venture which subsequently opened in 1983. In 1980, Tim joined Solvay as Far East Director for Solvay’s Biochem Products division, a JV with the Pasteur Institute developing both both human health and agricultural insecticides. In 1987 he became General Manager, Far East, of Porton International, a British biopharmaceuticals company. He successfully established marketing, distribution and local R&D for these companies across Asia. Later, working as an independent consultant he built a marketing and distribution network in Asia for Ecogen, a U.S. agricultural biotechnology company, and was also responsible for negotiating a “first mover” supply agreement for bulk antibiotics between a Chinese producer and British veterinary pharmaceutical companies. In 1993 he was appointed Vice President of Lotus Healthcare Corporation, a manufacturer of oral controlled-release morphine and other medicinal narcotics in China. He was responsible for business development, sourcing of Chinese pharmaceutical raw materials, and all in-licensing and technology transfer for Lotus which included upgrading China’s production of bulk opiates. In 1997 he established Phoenix Lifesciences and in 2007 its associate company Phoenix Innovation, providing transactional consultancy services to the pharmaceutical, life science and high technology sectors in Greater China and SE Asia. At Phoenix Tim has worked on a variety of projects with multinational companies such as AstraZenica, Authentix, Aventis, bioMérieux, Proctor & Gamble, SciClone and Xenova, as well as several Asian companies. His areas of expertise include business development, planning and contract negotiation, regulatory issues facing western companies, technology licensing and transfer, and the organization of marketing, distribution and local sourcing in the Greater China / SE Asia region. |
| Tan Boon Seng Mr. Tan Boon Seng, aged 55, is an experienced and successful businessman and his family, the Tan family of Malaysia, is widely recognized and one of the most successful families in South East Asia. The Tan family flagship company is IGB Corporation Berhad, a listed company in Malaysia (http://www.igbcorp.com). IGB and other family enterprises control other listed companies in Asia. Mr. Tan is an Executive Director of IGB. He joined IGB in 1980 as General Manager and was appointed to the Board on 20 December 1990, Managing Director in 1991 and subsequently, Executive Director in May 2001. He is the IGB Exco Chairman and a member of Risk Management and Share Committees. In addition Mr. Tan is Managing Director of Lee Hing Development Company Limited, a listed company in Hong Kong. Mr. Tan has been Managing Director of Lee Hing since 1989 and has been a director since 1987. Under Mr. Tan’s management, Lee Hing acquired a controlling interest in the prestigious luxury resort company, Amanresorts. After holding the position in Amanresorts for several years, Lee Hing sold Amanresorts profitably. Again under Mr. Tan’s leadership, Lee Hing has launched a new luxury hospitality company. Mr. Tan holds a Master of Arts from Cambridge University, United Kingdom. He is a director of Wo Kee Hong (Holdings) Limited and Genting Hong Kong Limited, all of which are listed on The Stock Exchange of Hong Kong Limited. |
| Stephen L. Parr Director Steve Parr is President and Managing Member of Parr Financial Group, LLC. Parr Financial Group, LLC is an asset management company with a focus on China, Asia and the international markets. Mr. Parr has been an active investor in China for over thirty years. Prior to founding Parr Financial Group, Mr. Parr was one of the Managing Directors of Memphis-based Pope Asset Management, which managed approximately $400-million. He advised Pope on investment strategy and was Pope's macro economic and political analyst. Mr. Parr also served as a vice-president and international specialist at Goldman Sachs from 1977 to 1995 performing portfolio management for individuals. Until joining Pope in 2001, he successfully provided financial and strategic advice to a large number of private and public companies. Mr. Parr is originally from Little Rock and attended Vanderbilt on a football scholarship, majoring in East Asian history. He joined Goldman Sachs directly upon graduation from Emory’s graduate school of business with an MBA in finance. His deep interest in China and investments therein began in 1974 and he has invested over $500 million in China since that time. |
| James Guy Tucker Director Mr. Tucker is a founder of Pacific GeneTech and Arkansas Biosciences and a Director of PGT. Since 1982, Mr. Tucker has been a founder, investor and Chairman of multiple successful companies in the United States and Asia, including cable television, and Internet companies in Arkansas, Florida, and Texas, and public companies in London and Hong Kong with cable/internet systems in the U.K. and Indonesia. He received his A.B. in government from Harvard College and his Juris Doctor from the University of Arkansas. He has served as an elected Prosecuting Attorney, Attorney General of Arkansas, Member of the United States Congress, Chairman of the White House Conference on Families under Presidents Carter and Reagan, Lt Governor and Governor of Arkansas (1992-1996). From 1982 -1992, Mr. Tucker was a senior partner in the 50-member law firm of Mitchell, Williams, Selig and Tucker in Little Rock where he handled complex regional and nationwide business litigation. All information on this website has been copyrighted by the company Pacific Gene-Tech and this website is purely to promote and not to be beneficial in any manner. This information does not belong to me it belongs to the company of Pacific Gene-Tech. |
